Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2838)	6/30/2010 11:58:33 AM
From: Jibacoa	1 Recommendation Read Replies (1) \| Respond to of 3722

RPTP was up 12% and is still up 5.24% at present on volume almost half its ADV bigcharts.marketwatch.com RTPT announced today that it has entered into an exclusive agreement with UniPharma to commercialize its Convivia in Taiwan. RPTP had announced positive results from a PIIa of Convivia in subjects with ALDH2 deficiency, in Nov2008. There is no ACTAY The stock has a good amount of resistance at the $3 level. It is trying to get off from the near term DT coming from the May3 H at $3.88 bigcharts.marketwatch.com However, with some good news, the stock could have plenty of room to run.<g> bigcharts.marketwatch.com Bernard